Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(14 sites)
United States
University of Southern California, Los Angeles, California Hoag Memorial Hospital, Newport Beach, California University of Colorado Cancer Center, Aurora, Colorado Yale Cancer Center, New Haven, Connecticut Kellogg Cancer Center, Evanston, Illinois Community Health Network, Indianapolis, Indiana Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland University of Michigan, Ann Arbor, Michigan START Midwest, Grand Rapids, Michigan Memorial Sloan Kettering Cancer Center, New York, New York The Christ Hospital, Cincinnati, Ohio Women & Infants Hospital, Providence, Rhode Island M.D. Anderson Cancer Center, Houston, Texas Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin